Jubilant Pharmova Limited

Jubilant Pharmova Limited (JUBLPHARMA) is a small-cap Healthcare company valued at ₹15,043 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Jubilant Pharmova Limited last traded at ₹933.5, modestly down 0.58% on the day.

Recent developments

On 2026-07-24, the company announced a dividend of ₹5.00 per share, with the ex-date set for that day. Promoter holding remained at 47.68% as of 2026-06-30, but 6.58% of promoter shares were pledged. Domestic institutional holding increased by 0.78 percentage points in the quarter.

Financial performance

The company's annual revenue rose 14.5% to ₹8,280 crore, but net profit fell 52.5% to ₹398 crore. In the latest quarter, revenue increased 17.3% to ₹2,229 crore, while net profit dropped 44.7% to ₹56 crore, reflecting a widening gap between revenue growth and profit performance.

Valuation multiples

The stock trades at 37.1 times earnings, a premium to the Healthcare median of 32.0, 2.30 times book value. It yields 0.5%.

Things to watch

Net profit margin fell 6.8 percentage points to 4.8%, and return on equity dropped to 5.6%. The stock is 15.7% below its 52-week high, and net profit has swung from a loss of ₹65 crore to a profit of ₹398 crore over the past three years.

Where it stands

The company's revenue growth outpaced profit growth, with net profit declining sharply in both annual and quarterly terms. The stock's price is 15.7% below its 52-week high, and the net profit margin has dropped significantly. The most recent figure is the latest quarter net profit of ₹56 crore.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.